Patricia Yotnda

Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses.

Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells.

Use of a chimeric adenovirus vector enhances BMP2 production and bone formation.

Reduced inflammatory reactions to the inoculation of helper-dependent adenoviral vectors in traumatically injured rat brain.

Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine.

Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids.

Targeted delivery of adenoviral vectors by cytotoxic T cells.

An inducible caspase 9 safety switch for T-cell therapy.

Assembly of the kappa preB receptor requires a V kappa-like protein encoded by a germline transcript.

Engineering human tumor-specific cytotoxic T cells to function in a hypoxic environment.

Fiber-modified recombinant adenoviral constructs encoding hepatitis C virus proteins induce potent HCV-specific T cell response.

Hypoxic tumors and their effect on immune cells and cancer therapy.

KCa1.1 Potassium Channels Regulate Key Proinflammatory and Invasive Properties of Fibroblast-like Synoviocytes in Rheumatoid Arthritis.